Arkema reported second quarter sales growth with an improved EBITDA margin, beating analyst expectations, according to the company's earnings release.
The French specialty chemicals company announced its Q2 2026 earnings, which highlighted higher-than-expected margins and overall performance.
6.2%
Arkema shares rose following the Q2 earnings call.
The positive results were reflected in the stock price, as Arkema shares gained 6.2% after the earnings call.